1 70650sek
-0,9 %
Date:2026-05-15Time:18:00:00Latest report:Q1-2026List:Large CapTicker:AZN
Market Cap:2 646 775 msekEnterprise Value:2 892 498 msekNet Sales:60 439 musdEarnings:10 389 musdEmployees:0ISIN:GB0009895292

Ratios

10-year key figure history for AstraZeneca turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for AstraZeneca with index and moving average MA50 and MA200.

Stockprice:1 706,50
MA50:1 787,50
MA200:1 665,79
Price/MA200:2,4 %
RSI (14):39,8
Price/MA50:-4,5 %

Description

AstraZeneca is a global pharmaceutical company focused on the research, development and marketing of prescription medicines, primarily for the treatment of diseases in the therapeutic areas of respiratory, cardiovascular/metabolic and cancer. In addition to its core business, the company also has a focus on the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in all global regions and is headquartered in Cambridge, UK.